Access to anti-retroviral drugs, female in Jamaica
Jamaica: Access to anti-retroviral drugs, female was 62.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Jamaica, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Jamaica stood at 62.0%. That is the highest value across all 25 years on record.
That represents a change of up 1.6% on the previous year and up 59.0% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Jamaica peaked at 62.0% in 2024 and was at its lowest, 0.0%, in 2000.
Jamaica ranks 99th of 141 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Jamaica, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 6.0% | — |
| 2006 | 7.0% | +16.7% |
| 2007 | 11.0% | +57.1% |
| 2008 | 14.0% | +27.3% |
| 2009 | 20.0% | +42.9% |
| 2010 | 21.0% | +5.0% |
| 2011 | 24.0% | +14.3% |
| 2012 | 27.0% | +12.5% |
| 2013 | 36.0% | +33.3% |
| 2014 | 39.0% | +8.3% |
| 2015 | 41.0% | +5.1% |
| 2016 | 45.0% | +9.8% |
| 2017 | 50.0% | +11.1% |
| 2018 | 53.0% | +6.0% |
| 2019 | 59.0% | +11.3% |
| 2020 | 54.0% | -8.5% |
| 2021 | 58.0% | +7.4% |
| 2022 | 60.0% | +3.4% |
| 2023 | 61.0% | +1.7% |
| 2024 | 62.0% | +1.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 5.8% | 0.0% | 20.0% | 10 |
| 2010s | 39.5% | 21.0% | 59.0% | 10 |
| 2020s | 59.0% | 54.0% | 62.0% | 5 |
Countries ranked near Jamaica
More gender data for Jamaica
- Child population (UN estimates and projections) 468.29 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -1.89 % change on previous year (2030)
- Population 2,341 (2030)
- Working-age population (UN estimates and projections) 2,341 (2030)
- Population (UN estimates and projections), annual growth rate 0.0684 % change on previous year (2030)
- Age population, age 00, female, interpolated 15,460 (2025)
- Age population, age 00, male, interpolated 16,015 (2025)
- Age population, age 01, female, interpolated 15,603 (2025)
- Age population, age 01, male, interpolated 16,169 (2025)
- Age population, age 02, female, interpolated 15,800 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Jamaica?
- Access to anti-retroviral drugs, female in Jamaica was 62.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Jamaica?
- The highest recorded value was 62.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Jamaica?
- The lowest recorded value was 0.0% in 2000.
- How does Jamaica rank for access to anti-retroviral drugs, female?
- Jamaica ranks 99th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Jamaica?
- Over the last ten years it is up 59.0%. The long-run trend across the full record is volatile.
- Where does this Jamaica data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.